About Nyiro Gyula Korhaz
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Janssen Research & Development, LLC
3
ACADIA Pharmaceuticals Inc.
2
Sunovion
2
Newron Pharmaceuticals SPA
1
Clinical Trials at Nyiro Gyula Korhaz
During the past decade, Nyiro Gyula Korhaz conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 3 clinical trials were completed, i.e. on
average, 60% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Safinamide in Idiopathic Parkinson's Disease (IPD) With Motor Fluctuations, as add-on to Levodopa
2009-02-01
2012-03-01
Completed
549
Bipolar Maintenance Study of Lurasidone Adjunctive to Lithium or Divalproex
2011-06-01
2015-04-01
Completed
965
This is an Open-label, Multi-center, Extension Study Designed to Evaluate the Longer Term Safety, Tolerability and Effectiveness of Lurasidone, Flexibly Dosed, Adjunctive to Lithium or Divalproex for the Treatment of Subjects With Bipolar I Disorder Who Have Participated in Study D1050296
2012-06-01
2015-07-01
Completed
377
54135419SUI3001: A Study to Evaluate the Efficacy and Safety of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Adult Participants Assessed to be at Imminent Risk for Suicide
2017-06-09
2018-12-18
Completed
226
Extension Study of Pimavanserin for the Adjunctive Treatment of Schizophrenia
2017-01-01
2024-03-01
Recruiting
500
Efficacy and Safety of Pimavanserin as Adjunctive Treatment for the Negative Symptoms of Schizophrenia
2020-08-05
2024-01-01
Recruiting
426
A Study of Aticaprant as Adjunctive Therapy in Adult Participants With Major Depressive Disorder (MDD) With Moderate-to-severe Anhedonia and Inadequate Response to Current Antidepressant Therapy
2022-06-22
2024-08-11
Recruiting
538
A Study of Aticaprant in Adult and Elderly Participants With Major Depressive Disorder (MDD)
2022-09-22
2025-10-25
Recruiting
840
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Nyiro Gyula Korhaz
According to Clinical.Site data, the most researched conditions in "Nyiro Gyula Korhaz" are
"Depressive Disorder, Major" (3 trials), "Bipolar I Disorder" (2 trials), "Schizophrenia" (2 trials), "Anhedonia" (1 trials) and "Idiopathic Parkinson's Disease" (1 trials). Many other conditions were trialed in "Nyiro Gyula Korhaz" in a lesser frequency.
Clinical Trials Intervention Types at Nyiro Gyula Korhaz
Most popular intervention types in "Nyiro Gyula Korhaz" are "Drug" (8 trials) and "Other" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (4 trials), "Aticaprant" (2 trials), "Lurasidone" (2 trials), "Pimavanserin" (2 trials) and "Esketamine" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Nyiro Gyula Korhaz
The vast majority of trials in "Nyiro Gyula Korhaz" are
8 trials for "All" genders.
Clinical Trials Status at Nyiro Gyula Korhaz
Currently, there are NaN active trials in "Nyiro Gyula Korhaz".
undefined are not yet recruiting,
4 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 4 completed trials in Nyiro Gyula Korhaz,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Nyiro Gyula Korhaz, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 8 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".